Sarah Speight
Key details
- Title: Senior Writer
- Email:sspeight@lifesciencesipreview.com
- Telephone: +44 (0)20 330 18210
Total results: 187
Articles by Sarah Speight
Pharma
Case dismissed with settlement between Novartis and Daiichi Sankyo unit | Melanoma therapy at centre of feud after Novartis faced infringement claims over Tafinlar. 7 December 2023
Americas
Two new partners, who have been appointed at the Canadian law firm’s Toronto office, bring ‘extensive’ track records of success in complex patent litigation. 5 December 2023
Pharma
Rival drugmakers have dropped lawsuit following invalidation of Teva patents in September | Move comes after judge overturned jury verdict handing $176.5m to Teva. 28 November 2023
article
With his ‘extensive’ scientific background and links to Nobel-Prize-winning inventions, Christopher North brings a wealth of experience and knowledge to Panitch Schwarze’s patent team. 28 November 2023
Pharma
US Court of Appeals dismisses appeal due to a ‘lack of jurisdiction’ | Dispute against Jiangsu Hengrui Pharmaceuticals began as a patent suit but the discovery process prompted trade secret claims. 31 October 2023
MedTech
Medical device company prevails after requesting inter partes reviews of three related patents | Patent Trial and Appeal Board finds obviousness in patents describing joint tissue repair and stabilisation. 17 October 2023
Asia
Japanese chemical company accuses Cocrystal of stealing its coQ10 formula for a health supplement | Kaneka says it's willing to sue customers of the accused product as well. 10 October 2023
Pharma
Amneal Pharmaceuticals fends off CMP’s US lawsuit alleging infringement of the blood pressure treatment / Dispute centres on whether suspension agents were used in “substantially the same way”. 3 October 2023
Biotech
The spatial biology firm will appeal the Unified Patent Court’s preliminary injunction | NanoString accuses 10x of ‘misusing non-final court rulings…to eliminate competition in the spatial transcriptomics market’. 21 September 2023
Biotech
Decision marks first announcement by the UPC of an injunction in open court | Ruling in Munich Local Division forecast to have far-reaching consequences for defendant| Comment from 10x vice president of IP and litigation, Randy Wu. 19 September 2023
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.